The present authors carried out an open up-label pilot research that administered psilocybin to fifteen procedure-resistant tobacco/nicotine-dependent people who smoke, during the context of cognitive behavioral therapy for smoking cessation [58]. Individuals had been administered ~0.29 mg/kg oral psilocybin about the participant’s concentrate on